Emcure Pharmaceuticals Limited (BOM:544210)

Emcure Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	4,896	1,555	1,690	2,423	1,628	4,687
Short-Term Investments	225.15	760.43	2,997	2,045	-	148.4
Cash & Short-Term Investments	5,121	2,316	4,687	4,468	1,628	4,836
Cash Growth	120.34%	-50.59%	4.88%	174.38%	-66.33%	195.16%
Accounts Receivable	22,999	20,022	18,588	16,483	13,085	14,754
Other Receivables	894.7	531.97	731.86	703.62	461.91	124.13
Receivables	23,893	20,554	19,320	17,187	13,547	14,878
Inventory	23,046	19,885	15,891	14,593	15,593	15,525
Prepaid Expenses	-	326.05	304.41	198.6	330.53	160.49
Other Current Assets	3,996	2,477	2,397	1,912	3,142	1,776
Total Current Assets	56,055	45,559	42,599	38,359	34,241	37,175
Property, Plant & Equipment	24,398	24,271	23,972	22,148	19,855	19,332
Long-Term Investments	193.86	221.26	199.85	557.78	440.37	10.99
Goodwill	3,948	3,678	3,787	2,177	2,174	3,975
Other Intangible Assets	6,168	5,792	5,078	1,258	1,614	3,832
Long-Term Deferred Tax Assets	1,231	1,110	967.96	991.26	1,161	1,483
Other Long-Term Assets	1,930	1,696	1,458	1,234	1,150	2,267
Total Assets	93,925	82,327	78,062	66,725	60,635	68,074
Accounts Payable	17,254	14,796	13,094	10,861	11,252	9,722
Accrued Expenses	625.99	2,571	2,418	2,782	2,457	2,612
Short-Term Debt	10,247	4,747	9,486	11,333	10,866	12,542
Current Portion of Long-Term Debt	-	670.79	3,721	3,175	2,797	3,623
Current Portion of Leases	394.34	337.28	319.19	241.9	222.96	324.43
Current Income Taxes Payable	1,070	1,123	534.45	487.75	621.52	616.91
Current Unearned Revenue	-	-	-	178.65	271.39	367.07
Other Current Liabilities	7,269	2,438	2,532	1,132	1,160	4,274
Total Current Liabilities	36,860	26,683	32,105	30,192	29,648	34,082
Long-Term Debt	3,194	1,899	7,666	7,441	7,173	7,040
Long-Term Leases	2,757	2,573	2,157	1,152	1,113	1,168
Long-Term Unearned Revenue	142.87	300.25	403.08	307.32	393.7	456.02
Long-Term Deferred Tax Liabilities	1,112	1,200	1,374	388.95	426.14	398.83
Other Long-Term Liabilities	1,019	3,256	3,139	747.37	739.54	1,249
Total Liabilities	45,085	35,912	46,844	40,229	39,493	44,394
Common Stock	1,896	1,895	1,812	1,809	1,809	1,809
Additional Paid-In Capital	-	7,853	98.84	-	-	840.37
Retained Earnings	-	33,767	26,980	22,789	17,751	19,191
Comprehensive Income & Other	45,530	947.24	632.25	413.54	315.91	890.31
Total Common Equity	47,426	44,462	29,523	25,011	19,875	22,730
Minority Interest	1,415	1,954	1,695	1,485	1,266	949.92
Shareholders' Equity	48,840	46,416	31,218	26,497	21,141	23,680
Total Liabilities & Equity	93,925	82,327	78,062	66,725	60,635	68,074
Total Debt	16,592	10,227	23,350	23,343	22,172	24,698
Net Cash (Debt)	-11,472	-7,912	-18,663	-18,875	-20,544	-19,862
Net Cash Per Share	-60.56	-42.30	-103.18	-104.37	-113.59	-109.82
Filing Date Shares Outstanding	189.47	189.48	181.15	180.85	180.85	180.85
Total Common Shares Outstanding	189.47	189.48	181.15	180.85	180.85	180.85
Working Capital	19,195	18,876	10,494	8,167	4,593	3,093
Book Value Per Share	250.31	234.65	162.97	138.30	109.90	125.68
Tangible Book Value	37,309	34,992	20,658	21,576	16,088	14,923
Tangible Book Value Per Share	196.92	184.67	114.04	119.30	88.96	82.52
Land	-	529.12	526.46	533.22	522.55	42.28
Buildings	-	6,199	5,953	5,478	4,901	4,609
Machinery	-	27,491	25,498	20,713	18,271	17,526
Construction In Progress	-	1,241	1,323	4,035	3,098	2,216
Leasehold Improvements	-	656.11	583.3	368.83	324.63	1,798

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.